Serial Number | 98585319 |
Word Mark | T |
Filing Date | Wednesday, June 5, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, March 11, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, March 11, 2025 |
Description of Mark | The mark consists of a design in the shape of a light blue puzzle piece surrounding a white letter "T". |
Goods and Services | Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling in the field of scientific and pharmaceutical research and development; downloadable software for research and development in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization, namely, scientific analysis of genetic sequences; downloadable software for the managing, analysis, and visualization of biological data |
Goods and Services | Pharmaceutical preparations for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; chemical and biological pharmaceutical preparations for medical purposes for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use namely, for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; immunotherapeutic drugs namely, for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; living cells for medical use; biological preparations for use in cell cultures for medical purposes, namely for T-cell therapy, gene therapy and cell therapy; biological and pharmaceutical preparations in the form of living cells for medical use in the treatment of immunological diseases; T-cell therapy pharmaceutical preparations for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; pharmaceutical preparations in the nature of genetically modified immune cells for the treatment of cancer |
Indication of Colors claimed | The color(s) light blue and white is/are claimed as a feature of the mark. |
Goods and Services | Medical services; Medical services, namely providing medical diagnostic and prognostic services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; mice breeding services; medical services relating to the removal, treatment and processing of living human cells; medical services, namely treatment and preparation of living immune cells for medical use; immune cell therapy medical treatment services; medical testing for diagnostic or treatment purposes in the field of cell therapy and gene therapy; medical analysis for diagnostic and treatment purposes and medical consulting in connection with immunotherapy; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes |
Goods and Services | Live laboratory mice, namely, live transgenic mice |
Goods and Services | Scientific, medical and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for the treatment of, protection from and prevention of infections, cancer, disease, inflammation and autoimmune diseases; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; Platform as a service (PAAS) featuring computer software platforms for DNA analysis; Platform as a service (PAAS) featuring computer software platforms for use in DNA sequencing; software as a service (SAAS) services featuring software for analyzing DNA; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; Providing temporary use of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research purposes; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; biomedical research services in relation to developing transgenic mice; Biomedical research services, namely, preparation of biological samples in the nature of living cells for analysis and research purposes; Biological analysis, namely structural and functional analysis of genomes for cell therapy and gene therapy; drug discovery services in the field of cell therapy and gene therapy; pharmaceutical drug development services, namely, development of gene based medicines and therapies; pharmaceutical drug development services, namely, development of pharmaceutical and medical preparations and medicines in the field of cell therapy and gene therapy; research in the field of gene therapy and cell therapy |
International Class | 031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt. |
US Class Codes | 001, 046 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 5, 2024 |
Primary Code | 031 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 5, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 5, 2024 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 5, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, June 5, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | T-Therapeutics Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Cambridge CB216AL GB |
Party Name | T-Therapeutics Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Cambridge CB216AL GB |
Event Date | Event Description |
Wednesday, June 5, 2024 | NEW APPLICATION ENTERED |
Tuesday, December 17, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, December 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, December 18, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, December 18, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, February 13, 2025 | EXAMINERS AMENDMENT E-MAILED |
Thursday, February 13, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, February 13, 2025 | EXAMINER'S AMENDMENT ENTERED |
Thursday, February 13, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, February 13, 2025 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, February 13, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, February 13, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, February 13, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, February 18, 2025 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Tuesday, February 18, 2025 | ASSIGNED TO LIE |
Wednesday, March 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, March 11, 2025 | PUBLISHED FOR OPPOSITION |
Tuesday, March 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, December 18, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, December 18, 2024 | ASSIGNED TO EXAMINER |